SYBX
SYNLOGIC, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.96
−3.99%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-5.5%
Return on equity
-4.9%
Return on assets
-39.0%
Return on invested capital
0.00x
Asset turnover
-$3.8M
Cash from operations
$1.07
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026